|
|
|
Volumn 41, Issue 1057, 1999, Pages 64-66
|
|
Amprenavir: A new HIV protease inhibitor
[No Author Info available]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ABACAVIR;
ADEFOVIR;
ADEFOVIR DIPIVOXIL;
AMPRENAVIR;
DELAVIRDINE;
DIDANOSINE;
EFAVIRENZ;
INDINAVIR;
LAMIVUDINE;
LAMIVUDINE PLUS ZIDOVUDINE;
NELFINAVIR;
NEVIRAPINE;
PROTEINASE INHIBITOR;
RITONAVIR;
RNA DIRECTED DNA POLYMERASE INHIBITOR;
SAQUINAVIR;
STAVUDINE;
ZALCITABINE;
ZIDOVUDINE;
CLINICAL TRIAL;
DIARRHEA;
DOSE CALCULATION;
DRUG ABSORPTION;
DRUG COST;
DRUG HALF LIFE;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
HYPERGLYCEMIA;
META ANALYSIS;
NAUSEA;
PARESTHESIA;
RASH;
SHORT SURVEY;
VOMITING;
ADMINISTRATION, ORAL;
ADOLESCENT;
ADULT;
ANTI-HIV AGENTS;
CARBAMATES;
CHILD;
CLINICAL TRIALS;
CROSS REACTIONS;
DIARRHEA;
DRUG ADMINISTRATION SCHEDULE;
DRUG INTERACTIONS;
DRUG RESISTANCE, MICROBIAL;
EXANTHEMA;
HIV INFECTIONS;
HIV PROTEASE INHIBITORS;
HUMANS;
NAUSEA;
STEVENS-JOHNSON SYNDROME;
SULFONAMIDES;
|
|
EID: 0033575261
PISSN: 0025732X
EISSN: None
Source Type: Journal
DOI: None Document Type: Short Survey |
|
Times cited : (3)
|
|
References (0)
|